## NBIS PE Stream Chart Analysis **Current Valuation Positioning (Latest Data Point):** As of the latest data point (mid-March 2026), NBIS is trading at a monthly average price of approximately **$118.56**, which places it precisely at — and effectively breaching — the **272.7x PE boundary** (the "Warning" zone upper threshold, with a boundary price of ~$118.56). This positions the stock at the very top of the PE stream framework, above the **228.2x PE** boundary (~$99.20) and right at the **272.7x PE** ceiling (~$118.56), firmly within the **Warning** zone. This extreme valuation signals that the stock is trading at a historically elevated earnings multiple, suggesting significant market optimism or speculative premium is priced in. **Historical Valuation Trend:** NBIS has undergone a dramatic and rapid valuation re-rating since late 2024. In Q4 2024, the stock traded at modest price levels (around $20–$30), well below the PE stream boundaries that only begin from mid-2025 onward in the available data, indicating the stock was either in an early-stage or pre-earnings phase with limited PE comparability. From Q2 2025 onward, the stock surged aggressively — climbing from ~$48 in Q2 2025 through ~$66 in Q3 2025, then spiking to a peak of ~$121 in Q4 2025 (October), before pulling back to ~$90–$98 in Q4 2025–Q1 2026. Notably, the PE stream boundaries themselves shifted significantly downward between Q3 2025 and Q4 2025 (e.g., the 272.7x boundary dropped from ~$255 to ~$118.56), reflecting a meaningful revision in underlying earnings estimates — likely an EPS downgrade — which paradoxically caused the stock's PE positioning to jump dramatically higher even as the price stabilized. Throughout this period, the stock has consistently traded within the **Overvalued** to **Warning** interval, and the current price sitting at the 272.7x boundary underscores that NBIS remains at an extreme valuation level. Investors should exercise caution, as the PE river chart trend reflects both earnings instability and elevated speculative pricing, making this stock less suitable for traditional PE-based valuation analysis.